-
1
-
-
0028877539
-
Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
-
Petros AJ, Marshall JC, van Saene HKF. Should morbidity replace mortality as an endpoint for clinical trials in intensive care? Lancet 1995;345:369-371.
-
(1995)
Lancet
, vol.345
, pp. 369-371
-
-
Petros, A.J.1
Marshall, J.C.2
Van Saene, H.K.F.3
-
2
-
-
0019336207
-
The competing objectives of randomized trials
-
Sackett DL. The competing objectives of randomized trials. N Engl J Med 1980;303:1059-1060.
-
(1980)
N Engl J Med
, vol.303
, pp. 1059-1060
-
-
Sackett, D.L.1
-
3
-
-
0018640322
-
Controversy in counting and attributing events in clinical trials
-
Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. N Engl J Med 1979;301: 1410-1412.
-
(1979)
N Engl J Med
, vol.301
, pp. 1410-1412
-
-
Sackett, D.L.1
Gent, M.2
-
4
-
-
0029092928
-
Sepsis trials: Intersection of investigation, regulation, funding, and practice
-
Bernard GR. Sepsis trials: intersection of investigation, regulation, funding, and practice. Am J Respir Crit Care Med 1995;152:4-10.
-
(1995)
Am J Respir Crit Care Med
, vol.152
, pp. 4-10
-
-
Bernard, G.R.1
-
5
-
-
0023805341
-
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction:ISIS-2
-
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction:ISIS-2. Lancet 1988; August 13:349-360.
-
(1988)
Lancet
, vol.13 AUGUST
, pp. 349-360
-
-
-
6
-
-
0028932732
-
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
-
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
-
(1995)
Lancet
, vol.345
, pp. 669-685
-
-
-
7
-
-
0029976317
-
Adult respiratory distress syndrome: A systematic overview of incidence and risk factors
-
Garber BG, Hebert PC, Yelle JD, Hodder RV, McGowan J. Adult respiratory distress syndrome: a systematic overview of incidence and risk factors. Crit Care Med 1996;24:687-695.
-
(1996)
Crit Care Med
, vol.24
, pp. 687-695
-
-
Garber, B.G.1
Hebert, P.C.2
Yelle, J.D.3
Hodder, R.V.4
McGowan, J.5
-
8
-
-
0024333745
-
Sepsis syndrome: A valid clinical entity
-
Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. Sepsis syndrome: a valid clinical entity. Crit Care Med 1989;17:389-393.
-
(1989)
Crit Care Med
, vol.17
, pp. 389-393
-
-
Bone, R.C.1
Fisher, C.J.2
Clemmer, T.P.3
Slotman, G.J.4
Metz, C.A.5
Balk, R.A.6
-
10
-
-
0018076475
-
The importance of beta, the type II error and sample size in the design and interpretation of the randomized controlled trial: Survey of 71 "negative" trials
-
Freiman JA, Chalmers TC, Smith H, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized controlled trial: survey of 71 "negative" trials. N Engl J Med 1978;299: 690-694.
-
(1978)
N Engl J Med
, vol.299
, pp. 690-694
-
-
Freiman, J.A.1
Chalmers, T.C.2
Smith, H.3
Kuebler, R.R.4
-
11
-
-
0017042882
-
Design and analysis of randomized clinical trials requiring prolonged observation of each patient I. Introduction and design
-
Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient I. Introduction and design. Br J Cancer 1976;34:585-612.
-
(1976)
Br J Cancer
, vol.34
, pp. 585-612
-
-
Peto, R.1
Pike, M.C.2
Armitage, P.3
|